Overview

OTO-313 in Subjects With Unilateral Subjective Tinnitus

Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of OTO-313 in subjects with unilateral tinnitus and to determine the safety and tolerability of OTO-313 in subjects with unilateral tinnitus.
Phase:
Phase 2
Details
Lead Sponsor:
Otonomy, Inc.